Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.
about
Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virusABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus ProductionDifferent requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmissionNatural killer cell function and dysfunction in hepatitis C virus infection.Evolution of genetic and genomic features unique to the human lineage.The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry.Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators.CD81 and hepatitis C virus (HCV) infection.Hepatitis C virus evasion mechanisms from neutralizing antibodiesHepatitis C virus entry: beyond receptors.Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoprotein.The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C InfectionDepressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency.Plant-derived antivirals against hepatitis c virus infection.Monoclonal antibodies against occludin completely prevented hepatitis C virus infection in a mouse model.Blocking HCV entry as potential antiviral therapy
P2860
Q26783378-45848CA4-DFDB-4078-8C9A-A001722D1017Q27314827-EDC16CBB-4490-492A-ACC8-87163382CC08Q30541733-62C87D7C-A222-45DC-8B63-6E8F7F2AF7A0Q33892695-AAE9AD2E-BFE4-4AD1-8207-C1A56E82AD49Q33900428-F0CAB2C7-5BC4-40DF-98BA-E61F5DDC6201Q34414075-F2B933DD-D05F-440E-B318-69C6D896316DQ35839680-2E9FCBAC-06CD-4308-9951-D5D4367607B9Q36968841-0C6470EE-52DE-4F58-980C-766076145D9BQ37611819-0E5B2873-D9F7-4FD8-A1BB-7202F0B2008DQ37967737-1573F14F-2716-42C8-B60A-F11CA5C0B5DEQ37990884-75CF6FD7-BE95-4187-A1AF-A343DD05FA65Q38964215-6108B4F7-1CDA-4CB4-87B1-B0BA7DDF827BQ39068693-1DC0AEB2-8BC2-4E35-B456-2E7C2EB53D5EQ39232151-327CC093-4AE1-4D9F-BC16-62F88F88EBF0Q39491188-AD3D167D-6DA1-4DE9-8175-5F0ED428BE8BQ41435455-90766515-E6D1-4FB7-8BE4-B637ED80B648Q42232478-255F826F-E4D3-4760-82AD-5AA18C2D6436Q49197977-6B5890AF-5259-4CCE-AAF0-63DA73FB48B4Q50043321-A0F9E14D-841C-45B0-A635-484FE4C71906Q57241788-9C74D0FE-3E1C-425C-976C-30E77E501D4F
P2860
Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Impact of intra- and interspec ...... c hepatitis C virus particles.
@en
Impact of intra- and interspec ...... c hepatitis C virus particles.
@nl
type
label
Impact of intra- and interspec ...... c hepatitis C virus particles.
@en
Impact of intra- and interspec ...... c hepatitis C virus particles.
@nl
prefLabel
Impact of intra- and interspec ...... c hepatitis C virus particles.
@en
Impact of intra- and interspec ...... c hepatitis C virus particles.
@nl
P2093
P2860
P356
P1433
P1476
Impact of intra- and interspec ...... c hepatitis C virus particles.
@en
P2093
Ahmed I Abdelaziz
Christian P Strassburg
Christoph Sarrazin
Heiner Wedemeyer
Ilka Wappler
Melanie Wicht
Michael P Manns
Nabila Hamdi
Sandra Ciesek
Sandra Westhaus
P2860
P304
P356
10.1128/JVI.00212-11
P407
P577
2011-06-01T00:00:00Z